Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lenz

Showing results (271-280 of 367) with videos related to

Pageof 37
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerC Bokemeyer, C-H Köhne, F Ciardiello, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stressD Banerjee, H J Lenz, B Schnieders, et al.
The Pharmacogenomics Journal|March 27, 2002
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyS T Pullarkat, J Stoehlmacher, V Ghaderi, et al.
The Pharmacogenomics Journal|September 16, 2015
Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancerA Sebio, S Matsusaka, W Zhang, et al.
The Pharmacogenomics Journal|July 27, 2011
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trialsP P Grimminger, M Shi, C Barrett, et al.
British Journal of Cancer|January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaA B El-Khoueiry, C Rankin, A B Siegel, et al.
The Pharmacogenomics Journal|August 10, 2016
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patientsY Ning, W Zhang, D L Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapyY Shirota, J Stoehlmacher, J Brabender, et al.
Nucleic Acids Research|February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)P V Danenberg, T Horikoshi, M Volkenandt, et al.
The Pharmacogenomics Journal|April 12, 2012
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrenceT Winder, P M Wilson, D Yang, et al.
Pageof 37

Showing results (271-280 of 367) with videos related to

Sort By:
Pageof 37
European Journal of Cancer (Oxford, England : 1990)|May 5, 2015
FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancerC Bokemeyer, C-H Köhne, F Ciardiello, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|November 1, 1995
Transfection of wild-type but not mutant p53 induces early monocytic differentiation in HL60 cells and increases their sensitivity to stressD Banerjee, H J Lenz, B Schnieders, et al.
The Pharmacogenomics Journal|March 27, 2002
Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapyS T Pullarkat, J Stoehlmacher, V Ghaderi, et al.
The Pharmacogenomics Journal|September 16, 2015
Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancerA Sebio, S Matsusaka, W Zhang, et al.
The Pharmacogenomics Journal|July 27, 2011
TS and ERCC-1 mRNA expressions and clinical outcome in patients with metastatic colon cancer in CONFIRM-1 and -2 clinical trialsP P Grimminger, M Shi, C Barrett, et al.
British Journal of Cancer|January 16, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinomaA B El-Khoueiry, C Rankin, A B Siegel, et al.
The Pharmacogenomics Journal|August 10, 2016
Clinical relevance of EMT and stem-like gene expression in circulating tumor cells of metastatic colorectal cancer patientsY Ning, W Zhang, D L Hanna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2001
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapyY Shirota, J Stoehlmacher, J Brabender, et al.
Nucleic Acids Research|February 11, 1992
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s)P V Danenberg, T Horikoshi, M Volkenandt, et al.
The Pharmacogenomics Journal|April 12, 2012
An individual coding polymorphism and the haplotype of the SPARC gene predict gastric cancer recurrenceT Winder, P M Wilson, D Yang, et al.
Pageof 37